If vesicoureteral reflux is left untreated, it can lead to severe complications such as renal scarring, hypertension, and chronic kidney disease. Recurrent infections further exacerbate these risks.

Ongoing research in VUR focuses on less invasive treatments, genetic understanding, and long-term kidney protection. Advances in endoscopic procedures, robotic surgery, and preventive strategies promise improved outcomes.

Emerging therapies targeting genetic causes and urinary tract development may revolutionize management, allowing early interventions and personalized care. These developments aim to reduce infections, preserve kidney function, and enhance quality of life for patients.

Regular monitoring, early intervention, and preventive measures are crucial to avoid these long-term consequences. Surgical correction in severe cases can effectively prevent permanent kidney damage.